Latest Manufacturing News

Aurora Labs has secured its first $250,000 order for AU4 propulsion engines from Sovereign Propulsion Systems, marking a key step in its commercialisation strategy targeting unmanned aerial vehicles and defence markets.

Immuron Limited reports topline results from a Uniformed Services University trial of a third-party ETEC product that missed its primary endpoint, reaffirming commitment to its established Travelan dosing ahead of FDA discussions.

Firebird Metals has achieved a significant technical milestone with its manganese iron phosphate precursor outperforming China industry benchmarks, setting the stage for commercial production at its Australian Demonstration Plant in 2026.

Tempest Minerals has signed a binding option agreement with Green Steel and Iron to develop a green steel facility in Western Australia, integrating its Remorse magnetite project into a low-emission steelmaking venture.

PWR Holdings has appointed Sharyn Williams as its new CEO and Managing Director, marking a strategic leadership transition while the search for a new CFO is underway.

Beetaloo Energy has received a groundbreaking approval from the Northern Territory Government, enabling pilot gas production and sales from EP187 and advancing construction of the Carpentaria Gas Plant.

Liontown Limited has inked a binding two-year offtake agreement with Canmax Technologies for 150,000 wet metric tonnes of spodumene concentrate annually in 2027 and 2028, reinforcing its foothold in the lithium supply chain.

Theta Gold Mines has taken a significant step forward in its TGME Gold Project by securing key long-lead processing equipment from leading South African engineering firms, keeping its commissioning timeline on track for the end of 2026.

Pinnacle Minerals has restarted exploration at its strategically located Adina East Lithium Project in Quebec’s James Bay region, aiming to capitalize on a booming lithium corridor amid rising market prices.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

DXN Limited has landed a $1.4 million contract for an Edge Data Centre in the Pacific and secured $0.7 million in variation orders on an existing project, reinforcing its growth trajectory for FY26.

Imugene has secured FDA backing to advance its allogeneic CAR T therapy, azer-cel, into a pivotal Phase 3 trial targeting difficult-to-treat diffuse large B-cell lymphoma (DLBCL), including patients relapsed after prior CAR-T treatment.